Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

ATAI Life Sciences N.V.

NAS: ATAI

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
ATAI Life Sciences N.V.

After Hours

ATAI
/zigman2/quotes/227454864/composite

$

10.58

Change

0.00 0.00%

Volume

Volume 439

Dec 6, 2021, 6:52 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/227454864/composite

Previous close

$ 10.58

$ 10.58

Change

0.00 0.00%

Day low

Day high

$10.25

$10.90

Open
Open: 10.63

52 week low

52 week high

$10.25

$22.91

Open

Market cap

$1.70B

Average volume

495,790

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.04

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/atai

MarketWatch News on ATAI

  2. ATAI Life Sciences started at buy with $28 stock price target at Canaccord Genuity

    10:56 a.m. July 13, 2021

    - Tomi Kilgore

  3. Peter Thiel's Atai Life Sciences and 5 Other Companies List Shares

    4:19 p.m. June 18, 2021

    - Barron's Online

/news/nonmarketwatch/company/us/atai

Other News on ATAI

  4. 10-Q: ATAI LIFE SCIENCES N.V.

    1:52 p.m. Nov. 15, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  10. These 4 Psychedelic Biotech Stocks Are Leading the Pack

    5:50 a.m. Oct. 26, 2021

    - Motley Fool

  15. Time to Buy the Magic Stocks? Magic Mushrooms, That Is.

    11:39 a.m. Sept. 8, 2021

    - 247WallSt.com

  17. 10-Q/A: ATAI LIFE SCIENCES N.V.

    4:06 p.m. Aug. 20, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  21. Loading more headlines...
/news/pressrelease/company/us/atai

Press Releases on ATAI

  2. Use of Ketamine for Mental Disorders Rising While New Therapies Emerge

    8:52 a.m. Nov. 17, 2021

    - Financial News Media

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.